Roche's novel Xenical ad campaign

Roche's two new direct-to-consumer television advertising spots for the anti-obesity drug Xenical seem to be in compliance with the letter of US Food and Drug Administration law, yet they could be misleading to consumers. Neither spot mentions any of the gastrointestinal side-effects common to users of the drug.